Search Within

Gary Schwartz

Formats
  1. Journal Article (191)
  2. Meeting Abstract (190)
  3. Conference Paper (3)
  4. Book Section (1)
Groups
  1. Department of Medicine (215)
  2. Solid Tumor Oncology Division (205)
  3. Melanoma Disease Management Team (129)
  4. Center for Pancreatic Cancer Research (99)
  5. Gastrointestinal Oncology Service (99)
  6. GSK Faculty (91)

More Groups

People
  1. David Kelsen (79)
  2. Richard Carvajal (61)
  3. Manish Shah (41)
  4. Mark Dickson (40)
  5. Eileen O'Reilly (36)
  6. Monica Motwani (36)

More People

Years
  1. 2023 (1)
  2. 2020 (1)
  3. 2018 (2)
  4. 2016 (3)
  5. 2015 (5)
  6. 2014 (23)

More Years

Publications
  1. Journal of Clinical Oncology (103)
  2. Cancer Research (42)
  3. Clinical Cancer Research (39)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (30)
  5. Annals of Oncology (12)
  6. Cancer (12)

More Publications

Publishers
  1. American Association for Cancer Research (121)
  2. American Society of Clinical Oncology (105)
  3. Elsevier Inc. (20)
  4. Springer (20)
  5. Oxford University Press (16)
  6. Wiley Blackwell (15)

More Publishers

Results (385)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mid and distal gastric cancers
    Book Section

    Harrison, L. E.; O’Reilly, E. M.; Minsky, B. D.; Schwartz, G. K.; Karpeh, M. S. Jr
    In Torosian, M. H. (Eds.) Integrated Cancer Management: Surgery, Medical Oncology, and Radiation Oncology (1999)

    Fulltext@MSK | Save
  • UCN-01 enhances 5-fluorouracil-induced apoptosis through caspase activation and ubiquitin-proteasome-dependent degradation of E2F-1
    Meeting Abstract

    Hsueh, C. T.; Schwartz, G. K.
    Proceedings of the American Association for Cancer Research Annual Meeting (1999)

    Fulltext@MSK | Save
  • The cyclin-dependent kinase (CDK) inhibitor flavopiridol (Flavo) accelerates mitotic exit of paclitaxel(P)-treated cells and enhances apoptosis by increasing paclitaxel-induced caspase activation
    Meeting Abstract

    Motwani, M.; Li, X. K.; Schwartz, G. K.
    Proceedings of the American Association for Cancer Research Annual Meeting (1999)

    Fulltext@MSK | Save
  • The cyclin-dependent kinase (CDK) inhibitor flavopiridol (Flavo) inhibits polyploidy in paclitaxel(P) treated p53-/- breast cancer cells
    Meeting Abstract

    Motwani, M.; Li, X. K.; Schwartz, G. K.
    Proceedings of the American Association for Cancer Research Annual Meeting (1999)

    Fulltext@MSK | Save
  • Combrestatin A-4 phosphate depletes tumor energy and enhances the effect of mitomycin C but not radiation in a murine mammary carcinoma (MCa)
    Meeting Abstract

    Koutcher, J. A.; Chen, Y.; Matei, C.; Pettit, G. R.; Schwartz, G. K.
    Proceedings of the American Association for Cancer Research Annual Meeting (1999)

    Fulltext@MSK | Save
  • 'Tomudex' (raltitrexed) plus 5-fluorouracil: A promising option for the treatment of patients with metastatic colorectal cancer
    Meeting Abstract

    Schwartz, G. K.; Bertino, J.; Kemeny, N.; Saltz, L.; Kelsen, D.; Tong, W.; Barazzuol, J.; Lowery, C.; Smith, M.
    European Journal of Cancer (1999)

    Fulltext@MSK | Save
  • The cyclin-dependent kinase (CDK) inhibitor flavopiridol (flavo) potentiates radiotherapy (RT) induced apoptosis in association with loss of p21(waf1/cip1)
    Meeting Abstract

    Jung, C. P.; Motwani, M. V.; Haimovitz-Friedman, A.; Schwartz, G. K.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • Phase I trial of sequential paclitaxel and cisplatin in combination with the cyclin dependent kinase inhibitor flavopiridol (flavo) in patients with advanced solid tumors
    Meeting Abstract

    Schwartz, G. K.; Kaubisch, A.; Saltz, L.; Ilson, D.; O'Reilly, E.; Barazzuol, J.; Endres, S.; Stoltz, M.; Tong, W.; Kelsen, D. P.; more...
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis
    Meeting Abstract

    Hsueh, C. T.; Kelsen, D. P.; Schwartz, G. K.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • Raltitrexed (Tomudex(TM)) in combination with 5-fluorouracil for the treatment of patients with advanced colorectal cancer: Preliminary results from phase I clinical trials
    Journal Article

    Schwartz, G. K.; Harstrick, A.; González Barón, M.
    European Journal of Cancer (1999)

    Fulltext@MSK | Save